BARCLAYS PLC - AXSOME THERAPEUTICS INC ownership

AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 2 filers reported holding AXSOME THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of AXSOME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,175
+23400.0%
16,810
+22927.4%
0.00%
Q2 2023$5
-100.0%
73
-99.7%
0.00%
-100.0%
Q3 2022$1,186,000
-40.4%
26,572
-56.0%
0.00%0.0%
Q3 2021$1,990,000
-71.6%
60,371
-41.8%
0.00%
-75.0%
Q2 2021$6,997,000
+252.7%
103,717
+196.0%
0.00%
+300.0%
Q1 2021$1,984,000
+113.1%
35,036
+206.5%
0.00%
Q4 2020$931,000
+14.2%
11,4320.0%0.00%
Q3 2020$815,000
-44.3%
11,432
-35.8%
0.00%
-100.0%
Q2 2020$1,464,000
-89.7%
17,793
-92.6%
0.00%
-90.9%
Q1 2020$14,175,000
-14.5%
240,971
+50.3%
0.01%
+10.0%
Q4 2019$16,573,000
+2639.3%
160,338
+436.2%
0.01%
Q3 2019$605,000
-78.2%
29,900
-72.3%
0.00%
-100.0%
Q2 2019$2,778,000
+6.7%
107,860
-41.1%
0.00%0.0%
Q1 2019$2,604,000
+8580.0%
182,975
+1642.6%
0.00%
Q4 2018$30,000
-74.4%
10,500
-71.2%
0.00%
Q2 2018$117,000
+34.5%
36,500
+2.5%
0.00%
Q1 2018$87,000
-10.3%
35,600
+103.4%
0.00%
Q3 2017$97,000
+9.0%
17,500
+8.1%
0.00%
Q2 2017$89,000
+196.7%
16,190
+106.1%
0.00%
Q1 2017$30,000
+2900.0%
7,857
+5552.5%
0.00%
Q4 2016$1,0000.0%1390.0%0.00%
Q3 2016$1,0001390.00%
Other shareholders
AXSOME THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 1,132,645$37,332,00032.86%
MORGAN JESS S & CO INC 113,430$3,739,0002.47%
Fairmount Funds Management LLC 187,598$6,183,0002.25%
IRIDIAN ASSET MANAGEMENT LLC/CT 1,423,653$46,924,0001.43%
WMS Partners, LLC 250,000$8,240,0001.21%
Beck Bode, LLC 102,127$3,366,0000.94%
RTW INVESTMENTS, LP 1,616,497$53,280,0000.80%
MPM BioImpact LLC 110,155$3,631,0000.56%
Endurant Capital Management LP 52,048$1,716,0000.39%
Bellevue Group AG 752,945$24,817,0000.25%
View complete list of AXSOME THERAPEUTICS INC shareholders